Scan-rescan reliability assessment of brain volumetric analysis across scanners and software solutions

Automated brain volumetry shows promise in improving the screening and monitoring of neurodegenerative diseases. However, the reliability of measurements across different scanners and software remains uncertain. This study assessed the reliability of gray matter, white matter, and total brain volume...

Full description

Saved in:
Bibliographic Details
Published inScientific reports Vol. 15; no. 1; pp. 29843 - 9
Main Authors Bürkle, Eva, Nazzal, Ahmad, Debolski, Alexander, Ernemann, Ulrike, Lindig, Tobias, Bender, Benjamin
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 14.08.2025
Nature Publishing Group
Nature Portfolio
Subjects
Online AccessGet full text
ISSN2045-2322
2045-2322
DOI10.1038/s41598-025-15283-3

Cover

Loading…
More Information
Summary:Automated brain volumetry shows promise in improving the screening and monitoring of neurodegenerative diseases. However, the reliability of measurements across different scanners and software remains uncertain. This study assessed the reliability of gray matter, white matter, and total brain volume measurements from seven volumetry tools, using six scanners across two scanning sessions, performed within 2 h the same day, in twelve subjects. Generalised estimating equations models showed significant effects of both software and scanner on all measurements with stronger effect of software ( p  < 0.001). Percentage of coefficient of variation (CV) was calculated to measure scan-rescan reliability. Median CV across scanners of AssemblyNet and AIRAscore was less than 0.2% for grey and white matter, and 0.09% for total brain volume; while FreeSurfer, FastSurfer, syngo.via, SPM12, and Vol2Brain had a CV greater than 0.2%. In Bland-Altman analysis there was no systematic difference, but limits of agreement differed greatly between methods. Based on these findings, we recommend using the same scanner and software combination across sessions to ensure that observed changes in brain volume are reliable and clinically valuable.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:2045-2322
2045-2322
DOI:10.1038/s41598-025-15283-3